Pay in installments of $7.18 with
,
and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 17 - Jul 22
Promo Codes Available:
For Your Every Summer RSVP, with Code: SUMMER15
Description
Semaglutide 5 mg 2 ml 2 ml vial Weight Loss Glucagon Like Peptide 1 (GLP 1) NDC The FDA has approved the drug Zepbound, which is similar to both Ozempic and Wegovy. The drug's active ingredient is called tirzepatide, and it was originally a diabetes drug sold under the How to Not Gain Weight After Stopping Ozempic: Effective Strategies What to Expect When You Stop Taking Semaglutide Banner
Shipping Notes
- Free Standard Shipping on $100+ Orders to the USA.
- Except Preorder products are shipped in 48 hours.
- Delivery to the USA:
- Standard Shipping : 3-10 business days
- If time is of the essence, please consider selecting expedited delivery for faster service.
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
4.8 ★★★★★
Based on 13 reviews
Sort
Product Reviews
★★★★★ 4
Works good
Color: Blue/Battery
Works good
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on January 24, 2026
★★★★★ 5
Handy to use
Color: Blue/Battery
Easy to use.
Stores easily.
Grateful to have.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 13, 2026
★★★★★ 5
Nice Opener.
Color: Blue/Battery
Works great, and as described.
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 8, 2026
★★★★★ 3
not for older ladies ...sigh
Color: Blue/Battery
its really neat , kinda magical but im older gen x and I h@te this thing too hard to coordinate for an old ladies hands
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on May 11, 2026
★★★★★ 5
Can opener
Color: Blue/Battery
Great can opener
WAS THIS REVIEW HELPFUL?YesReportShare
Reviewed in the United States on April 25, 2026